课题基金 / 基金详情

PROTOCOL #191622-057

PROTOCOL #191622-057
协议
批准号：
7951269
负责人：
THYAGARAJAN SUBRAMANIAN
金额：
$0.05万
依托单位：
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
依托单位国家：
美国
项目类别：
财政年份：
2009
资助国家：
美国
项目状态：
已结题
起止时间：
2009-04-01 至 2010-03-31
来源：
https://reporter.nih.gov/project-details/7951269
关键词：
BotoxClinical ResearchComputer Retrieval of Information on Scientific Projects DatabaseFundingGrantInstitutionMuscle TonusPatientsProtocols documentationResearchResearch PersonnelResourcesRespiratory DiaphragmRespiratory physiologyRiskSafetySourceStrokeUnited States National Institutes of Healthpulmonary function

项目摘要

项目成果

THYAGARAJAN SUBRAMANIAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The objective of this study is to assess the safety of BOTOX in terms of pulmonary function in patients with reduced lung function. BOTOX is used to reduce muscle tone and has been used to treat spasticity following a stroke. There is a risk that this treatment could compromise the diaphragm and pulmonary function.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Optogenetic and Chemogenetic Dissection of Cell Transplants
Optogenetic and Chemogenetic Dissection of Cell Transplants
A LONGITUDINAL OBSERVATIONAL FOLLOW-UP OF THE PRECEPT STUDY COHORT (POSTCEPT)
DRUG COMBINATION FOR PARKINSON'S DISEASE
海外基金